Cullinan Associates Inc Vertex Pharmaceuticals Inc Transaction History

Cullinan Associates Inc

  • $1.5 Billion
  • Q2 2025

A detailed history of Cullinan Associates Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cullinan Associates Inc holds 52,012 shares of VRTX stock, worth $21 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
52,012
Previous 53,112 2.07%
Holding current value
$21 Million
Previous $25.7 Million 10.07%
% of portfolio
1.55%
Previous 1.84%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 22, 2025
SELL
$421.16 - $509.5 $463,276 - $560,450
-1,100 Reduced 2.07%
52,012 $23.2 Million
Q1 2025

Apr 22, 2025
SELL
$402.49 - $513.76 $20,124 - $25,688
-50 Reduced 0.09%
53,112 $25.7 Million
Q4 2024

Jan 24, 2025
SELL
$396.64 - $516.74 $594,960 - $775,110
-1,500 Reduced 2.74%
53,162 $21.4 Million
Q3 2024

Oct 23, 2024
SELL
$460.0 - $505.78 $460,000 - $505,780
-1,000 Reduced 1.8%
54,662 $25.4 Million
Q2 2024

Jul 10, 2024
SELL
$392.81 - $485.53 $241,185 - $298,115
-614 Reduced 1.09%
55,662 $26.1 Million
Q1 2024

Apr 18, 2024
SELL
$407.69 - $446.08 $815,380 - $892,160
-2,000 Reduced 3.43%
56,276 $23.5 Million
Q4 2023

Jan 24, 2024
SELL
$343.0 - $410.68 $960,400 - $1.15 Million
-2,800 Reduced 4.58%
58,276 $23.7 Million
Q3 2023

Oct 11, 2023
SELL
$338.18 - $362.46 $304,362 - $326,214
-900 Reduced 1.45%
61,076 $21.2 Million
Q2 2023

Jul 14, 2023
SELL
$314.42 - $351.91 $817,492 - $914,966
-2,600 Reduced 4.03%
61,976 $21.8 Million
Q1 2023

Apr 05, 2023
SELL
$283.23 - $323.1 $86,385 - $98,545
-305 Reduced 0.47%
64,576 $20.3 Million
Q4 2022

Jan 11, 2023
SELL
$285.76 - $321.48 $5.54 Million - $6.24 Million
-19,400 Reduced 23.02%
64,881 $18.7 Million
Q3 2022

Oct 19, 2022
SELL
$273.83 - $305.53 $1.27 Million - $1.42 Million
-4,650 Reduced 5.23%
84,281 $24.4 Million
Q2 2022

Jul 08, 2022
SELL
$234.96 - $292.55 $2.21 Million - $2.75 Million
-9,385 Reduced 9.55%
88,931 $25.1 Million
Q1 2022

Apr 21, 2022
SELL
$221.42 - $260.97 $131,523 - $155,016
-594 Reduced 0.6%
98,316 $25.7 Million
Q4 2021

Jan 07, 2022
SELL
$177.01 - $223.45 $38,057 - $48,041
-215 Reduced 0.22%
98,910 $21.7 Million
Q3 2021

Oct 08, 2021
SELL
$181.39 - $202.99 $473,427 - $529,803
-2,610 Reduced 2.57%
99,125 $18 Million
Q2 2021

Jul 07, 2021
SELL
$187.49 - $221.1 $506,223 - $596,970
-2,700 Reduced 2.59%
101,735 $20.5 Million
Q1 2021

Apr 20, 2021
BUY
$207.02 - $241.31 $2.24 Million - $2.61 Million
10,800 Added 11.53%
104,435 $22.4 Million
Q4 2020

Jan 14, 2021
BUY
$207.01 - $276.09 $1.02 Million - $1.36 Million
4,925 Added 5.55%
93,635 $22.1 Million
Q3 2020

Oct 09, 2020
SELL
$255.65 - $303.1 $1.45 Million - $1.72 Million
-5,679 Reduced 6.02%
88,710 $24.1 Million
Q2 2020

Jul 07, 2020
BUY
$225.48 - $295.8 $333,033 - $436,896
1,477 Added 1.59%
94,389 $27.4 Million
Q1 2020

Apr 01, 2020
BUY
$199.77 - $247.81 $327,822 - $406,656
1,641 Added 1.8%
92,912 $22.1 Million
Q4 2019

Jan 15, 2020
SELL
$166.71 - $223.91 $1.8 Million - $2.42 Million
-10,824 Reduced 10.6%
91,271 $20 Million
Q2 2019

Jul 16, 2019
SELL
$164.61 - $190.37 $1.38 Million - $1.59 Million
-8,378 Reduced 7.58%
102,095 $18.7 Million
Q1 2019

Apr 30, 2019
SELL
$163.73 - $194.7 $1.11 Million - $1.32 Million
-6,800 Reduced 5.8%
110,473 $20.3 Million
Q4 2018

Jan 11, 2019
BUY
$151.91 - $192.21 $831,251 - $1.05 Million
5,472 Added 4.89%
117,273 $19.4 Million
Q3 2018

Oct 19, 2018
SELL
$167.73 - $192.74 $1.43 Million - $1.65 Million
-8,541 Reduced 7.1%
111,801 $21.5 Million
Q2 2018

Jul 09, 2018
BUY
$145.72 - $169.96 $3.18 Million - $3.7 Million
21,795 Added 22.12%
120,342 $20.5 Million
Q1 2018

Apr 27, 2018
BUY
$151.6 - $177.13 $90,960 - $106,278
600 Added 0.61%
98,547 $16.1 Million
Q4 2017

Jan 17, 2018
BUY
$137.28 - $155.55 $150,047 - $170,016
1,093 Added 1.13%
97,947 $14.7 Million
Q3 2017

Oct 16, 2017
BUY
$148.13 - $162.24 $14.3 Million - $15.7 Million
96,854
96,854 $14.7 Million

Others Institutions Holding VRTX

# of Institutions
1,809
Shares Held
239M
Call Options Held
1.95M
Put Options Held
1.14M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email